ARCHIVES

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

NIH Human Connectome Project To Map Brain Connections

July 31, 2009

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

Clarification: Full Text Of ACS Guideline On Prostate Screening

January 30, 1998

White House Group Calls For Improved Action Against Carcinogens

September 28, 1979

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011